Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis

dc.contributor.authorLi, Li
dc.contributor.authorGuturi, Kiran Kumar Naidu
dc.contributor.authorGautreau, Brandon
dc.contributor.authorPatel, Parasvi S.
dc.contributor.authorSaad, Amine
dc.contributor.authorMorii, Mayako
dc.contributor.authorMateo González, Francesca
dc.contributor.authorPalomero, Luis
dc.contributor.authorBarbour, Haithem
dc.contributor.authorGomez, Antonio
dc.contributor.authorNg, Deborah
dc.contributor.authorKotlyar, Max
dc.contributor.authorPastrello, Chiara
dc.contributor.authorJackson, Hartland W.
dc.contributor.authorKhokha, Rama
dc.contributor.authorJurisica, Igor
dc.contributor.authorAffar, El Bachir
dc.contributor.authorRaught, Brian
dc.contributor.authorSanchez, Otto
dc.contributor.authorAlaoui-Jmali, Moulay
dc.contributor.authorPujana Genestar, M. Ángel
dc.contributor.authorHakem, Anne
dc.contributor.authorHakem, Razq
dc.date.accessioned2020-11-17T13:44:57Z
dc.date.available2020-11-17T13:44:57Z
dc.date.issued2018-10-01
dc.date.updated2020-11-11T17:40:45Z
dc.description.abstractThe E3 ubiquitin ligase RNF8 plays critical roles in maintaining genomic stability by promoting the repair of DNA double-strand breaks (DSBs) through ubiquitin signaling. Abnormal activation of Notch signaling and defective repair of DSBs promote breast cancer risk. Here, we found that low expression of the full-length RNF8 correlated with poor prognosis for breast cancer patients. Our data revealed that in addition to its role in the repair of DSBs, RNF8 regulated Notch1 signaling and cell-fate determination of mammary luminal progenitors. Mechanistically, RNF8 acted as a negative regulator of Notch signaling by ubiquitylating the active NOTCH1 protein (N1ICD), leading to its degradation. Consistent with abnormal activation of Notch signaling and impaired repair of DSBs in Rnf8-mutant mammary epithelial cells, we observed increased risk of mammary tumorigenesis in mouse models for RNF8 deficiency. Notably, deficiency of RNF8 sensitized breast cancer cells to combination of pharmacological inhibitors of Notch signaling and poly(AOP-ribose) polymerase (PARP), suggesting implications for treatment of breast cancer associated with impaired RNF8 expression or function.
dc.format.extent18 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid30222135
dc.identifier.urihttps://hdl.handle.net/2445/172125
dc.language.isoeng
dc.publisherAmerican Society Clinical Investigation Inc.
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1172/JCI120401
dc.relation.ispartofJournal of Clinical Investigation, 2018, vol. 128, num. 10, p. 4525-4542
dc.relation.urihttps://doi.org/10.1172/JCI120401
dc.rights(c) American Society Clinical Investigation, 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationUbiqüitina
dc.subject.classificationReparació de l'ADN
dc.subject.otherUbiquitin
dc.subject.otherDNA repair
dc.titleUbiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
LiL.pdf
Mida:
21.29 MB
Format:
Adobe Portable Document Format